Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis | MicrobiomeTrials← Back to trialsNCT07750574
Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-11Est. Completion: 2028-11
Enrollment target: 105 participants Other microbiome trials you might be interested in
Polycythemia Vera
The trial will be a phase III, randomised-controlled, multi-centre, international, open-label trial consisting of ruxoli…
Aberdeen, United KingdomEst. completion Oct 31, 2028
Newly Diagnosed GlioblastomaMGMT-Unmethylated Glioblastoma
The Primary Objective of this study is to evaluate the efficacy and safety of teniposide in combination with temozolomid…
Multiple LocationsEst. completion Mar 2030
Phase 2
TERMINATED
Primary MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Myelofibrosis
This is a phase II, open label, prospective, single-arm study evaluating the efficacy and safety of selinexor in patient…
Salt Lake City, United StatesCompleted Aug 16, 2023